Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Malignant Mixed Germ Cell Tumors of the Ovary: A Series of Rare Cases

Authors
1 Department of Obstetrics and Gynaecology, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
2 Department of Pathology, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
Abstract
Background: Malignant mixed germ cell tumors of ovary are rare aggressive cancers affecting young adolescent girls. The commonest combination reported in literature is dysgerminoma and endodermal sinus tumors but in our study the most common combination was immature teratoma and endodermal sinus tumor which is exteremely rare. Preservation of future fertility is a concern. Fertility sparing surgery followed by combination chemotherapy is the current treatment of choice but treatment must be individualized depending upon the nature of the tumor. Methods: A retrospective study on five patients with these tumors was conducted on patients at Guru Gobind Singh Medical College and Hospital (Punjab, India) between September 2009 to January 2018. Results: Median age of patients was 15.6 years. Histopathological combination was immature teratoma and endodermal sinus tumor (n=3), endodermal sinus tumor and embryonal carcinoma (n=1), and mature and immature teratoma (n=1). Tumor markers AFP, beta HCG and LDH were raised in all except the patient with mature and immature teratoma. All patients underwent surgery followed by combination chemotherapy. Three patients developed metastasis within six months of treatment and died. In the remaining two, no reccurrence was reported till date. Conclusion: Malignant mixed germ cell tumors of ovary are extremely rare tumors and have poor prognosis. Fertility preservation is a concern as these patients are usually young adolescent girls but fertility sparing treatment must be individualized on the basis of tumor type, surgical staging, and availability of combination chemotherapy. Considering high recurrence rate and mortality, total hysterectomy with bilateral salpingo-oophorectomy with complete surgical staging followed by combination chemotherapy should be perfomed at advanced stage and aggressive tumor biology. Preservation of fertility must be held secondary.
Keywords

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.
  2. Bhurgri Y, Shaheen Y, Kayani N, Nazir K, Ahmed R, Usman A,et al. Incidence, trends and morphology of ovarian cancer in Karachi (1995-2002). Asian Pac J Cancer Prev. 2011;12(6):1567-71.
  3. Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of ovary. Cancer Treat Rev. 2008;34(5):427-41.
  4. Koshy M, Vijayananthan A, Vadiveloo V. Malignant ovarian mixed germ cell tumour: a rare combination. Biomed Imaging Interv J. 2005;1(2):e10.
  5. Munemane A, Munemane M. Malignant mixed germ cell tumours of the ovary- A report of 2 cases. Int J Med Sci Public Health. 2014;3(1):105-7.
  6. Tiwary B, Sinha H, Pandey V. Malignant mixed germ cell tumour of ovary: a rare case report. Int J Reprod Contracept Obstet Gynecol. 2015;4(2):511-3.
  7. Moniaga NC, Randall LM. Malignant mixed ovarian germ cell tumour with embryonal component. J Paediatr Adolesc Gynecol. 2011;24(1):e1-3.
  8. Bailey J, Church D. Management of germ cell tumours of the ovary. Rev Gynaecol Pract. 2005;5:201.
  9. Goyal LD, Kaur S, Kawatra K. Malignant mixed germ cell tumour of the ovary- an unusual combination and review of literature. J Ovarian Res. 2014;7:91.
  10. Malignant ovarian germ cell tumours. Royal College of Obstetricians and Gynaecologists. Scientific impact paper No. 2016;11:1-10.
  11. Mazumdar M, Bajorin DF, Bacik J, Higgins G, Motzer RJ, Bosl GJ. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. J Clin Oncol. 2001;19(9):2534-41.
  12. Gershensom DM. Treatment of ovarian cancer in young women. Clin Obstet Gynecol. 2012;55(1):65-74.
  13. Parkinson CA, Hatcher HM, Ajithkumar TV. Management of malignant ovarian germ cell tumors. Obstet Gynecol Surv. 2011;66(8):507-14.
  14. Nishio S, Ushijima K, Fukui A, Fujiyoshi N, Kawano K, Komai K, et al. Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary. J Obstet Gynaecol Res. 2006;32(4):416-21.
  15. Vazquez I, Rustin GJ. Current controversies in the management of germ cell tumours. Curr Opin Oncol. 2013;25(5):539-45.
  16. Lai CH, Chang TC, Hsueh S, Wu TI, Chao A, Chou HH, et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol. 2005;96(3):784-91.
  17. Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali-Fehmi R. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol. 2008;110(2):125-32.
  18. Smith JP, Rutledge F, Sutow WW. Mixed gynecologic tumors in children. current approaches to treatment. Am J Obstet Gynecol. 1973;116(2):261-70.
  19. Mangili G, Sigismondi C, Gadducci A, Cormio G, Scollo P, Tateo S, et al. Outcome and risk factors for recurrence in malignant ovarian germ cell tumours: a MITO-9 retrospective study. Int J Gynecol Cancer. 2011;21(8):1414-21.
  20. Zhao T, Zhang H, Liu Y, Jiang H, Wang X, Lu Y The role of staging surgery in the treatment of apparent early-stage malignant ovarian germ cell tumours. Aust N Z J Obstet Gynaecol. 2016;56(4):398-402.
  21. Mahdi H, Swensen RE, Hanna R, Kumar S, Ali-Fehmi R, Semaan A. Prognostic impact of pelvis lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Brit J Cancer. 2011;105(4):493-7.
  22. Reddihalli PV, Subbian A Umadevi K, Rathod PS, Krishnappa S, Nanaiah SP, et al. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort. Eur J Obstet Gynecol Reprod Biol. 2015;192:17-21.
  23. Cicin I, Saip P, Guney N, Eralp Y, Ayan I, Kebudi R, et al. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Eur J Obstet Gynecol Reprod Biol. 2009;146(2):210-4.
  24. Lee KH, Lee IH, Kim BG, Nam JH, Kim WK, Kang SB, et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women; A Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer. 2009;19(1):84-7.